Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study.

Ruffatti A, Tonello M, Visentin MS, Bontadi A, Hoxha A, De Carolis S, Botta A, Salvi S, Nuzzo M, Rovere-Querini P, Canti V, Mosca M, Mitic G, Bertero MT, Pengo V, Boffa MC, Tincani A.

Rheumatology (Oxford). 2011 Sep;50(9):1684-9. doi: 10.1093/rheumatology/ker139. Epub 2011 Jun 7.

PMID:
21652586
2.

Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy.

Ruffatti A, Tonello M, Cavazzana A, Bagatella P, Pengo V.

Thromb Res. 2009;123(3):482-7. doi: 10.1016/j.thromres.2008.03.012. Epub 2008 May 6.

PMID:
18462781
3.

Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study.

Ruffatti A, Salvan E, Del Ross T, Gerosa M, Andreoli L, Maina A, Alijotas-Reig J, De Carolis S, Mekinian A, Bertero MT, Canti V, Brucato A, Bremme K, Ramoni V, Mosca M, Di Poi E, Caramaschi P, Galeazzi M, Tincani A, Trespidi L.

Thromb Haemost. 2014 Oct;112(4):727-35. doi: 10.1160/TH14-03-0191. Epub 2014 Jul 10. Erratum in: Thromb Haemost. 2014 Dec;112(6):1327. Meroni, Pier Luigi [corrected to Trespidi, Laura].

PMID:
25008944
4.

Pregnancy outcome in systemic lupus erythematosus complicated by anti-phospholipid antibodies.

Mecacci F, Bianchi B, Pieralli A, Mangani B, Moretti A, Cioni R, Giorgi L, Mello G, Matucci-Cerinic M.

Rheumatology (Oxford). 2009 Mar;48(3):246-9. doi: 10.1093/rheumatology/ken458. Epub 2008 Dec 24.

PMID:
19109318
5.

A study of 100 high risk lupus pregnancies.

Buchanan NM, Khamashta MA, Morton KE, Kerslake S, Baguley EA, Hughes GR.

Am J Reprod Immunol. 1992 Oct-Dec;28(3-4):192-4. Review.

PMID:
1285876
6.

Risk-based secondary prevention of obstetric antiphospholipid syndrome.

Ruffatti A, Calligaro A, Del Ross T, Favaro M, Tonello M, Banzato A, Punzi L, Pengo V.

Lupus. 2012 Jun;21(7):741-3. doi: 10.1177/0961203312446388.

PMID:
22635219
7.

Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.

Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.

J Rheumatol. 2009 Jun;36(6):1195-9. doi: 10.3899/jrheum.081194. Epub 2009 May 15.

PMID:
19447935
8.

The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.

Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.

J Rheumatol. 2001 Dec;28(12):2637-43.

PMID:
11764209
9.

Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.

Salazar-Páramo M, Jara LJ, Ramos A, Barile L, Machado G, García-De La Torre I.

Rheumatol Int. 2002 Aug;22(4):142-7. Epub 2002 Jun 19.

PMID:
12172952
10.

A study of 75 pregnancies in patients with antiphospholipid syndrome.

Huong DL, Wechsler B, Bletry O, Vauthier-Brouzes D, Lefebvre G, Piette JC.

J Rheumatol. 2001 Sep;28(9):2025-30.

PMID:
11550970
11.

Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity.

Ruffatti A, Tonello M, Del Ross T, Cavazzana A, Grava C, Noventa F, Tona F, Iliceto S, Pengo V.

Thromb Haemost. 2006 Sep;96(3):337-41.

PMID:
16953276
12.

Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?

Gómez-Puerta JA, Martín H, Amigo MC, Aguirre MA, Camps MT, Cuadrado MJ, Hughes GR, Khamashta MA.

Medicine (Baltimore). 2005 Jul;84(4):225-30.

13.

Pregnancy outcomes in patients with systemic autoimmunity.

Canti V, Castiglioni MT, Rosa S, Franchini S, Sabbadini MG, Manfredi AA, Rovere-Querini P.

Autoimmunity. 2012 Mar;45(2):169-75. doi: 10.3109/08916934.2011.593600. Epub 2011 Aug 30.

PMID:
21875380
14.

Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.

Backos M, Rai R, Baxter N, Chilcott IT, Cohen H, Regan L.

Br J Obstet Gynaecol. 1999 Feb;106(2):102-7.

PMID:
10426674
15.

Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.

Muñoz-Rodríguez FJ, Reverter JC, Font J, Tàssies D, Cervera R, Espinosa G, Carmona F, Balasch J, Ordinas A, Ingelmo M.

Haematologica. 2000 Jun;85(6):632-7.

16.

Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study.

Bouvier S, Cochery-Nouvellon E, Lavigne-Lissalde G, Mercier E, Marchetti T, Balducchi JP, Marès P, Gris JC.

Blood. 2014 Jan 16;123(3):404-13. doi: 10.1182/blood-2013-08-522623. Epub 2013 Nov 7.

17.
18.

Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients.

Hereng T, Lambert M, Hachulla E, Samor M, Dubucquoi S, Caron C, Launay D, Morell-Dubois S, Queyrel V, Hatron PY.

Lupus. 2008 Jan;17(1):11-5.

PMID:
18089677

Supplemental Content

Support Center